Verrica Pharmaceuticals VRCA
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2026Q1 | 5.29 | 102.03 | -0.45 | -9,715 | -10 | |
| 2025Q4 | 8.31 | 102.65 | -0.65 | -7,192 | -8 | |
| 2025Q3 | 4.31 | 89.4 | -0.02 | 1,627 | 0 | |
| 2025Q2 | 5.3 | 64.67 | 0.02 | 1,510 | 0 | |
| 2025Q1 | 4.42 | 107.84 | -1.03 | -8,130 | -10 | |
| 2024Q4 | 7 | 81.87 | -1.82 | -11,410 | -16 | |
| 2024Q3 | 14.5 | -4.9 | -20,704 | -23 | ||
| 2024Q2 | 72.9 | 102.62 | -3.7 | -15,206 | -17 | |
| 2024Q1 | 59.2 | 103.26 | -0.44 | -18,599 | -20 | |
| 2023Q4 | 73.2 | 93.12 | -0.54 | -23,136 | -25 | |
| 2023Q3 | 38.85 | 103.34 | -0.54 | -23,918 | -25 | |
| 2023Q2 | 57.7 | 105.7 | -0.25 | -11,616 | -11 | |
| 2023Q1 | 65 | 107.59 | -0.15 | -7,089 | -7 | |
| 2022Q4 | 27.5 | 104.7 | -0.14 | -6,211 | -6 | |
| 2022Q3 | 29.2 | 898.14 | 1 | 1,446 | 0 | |
| 2022Q2 | 19.2 | 99.62 | -3.7 | -9,121 | -10 | |
| 2022Q1 | 81.1 | 100.3 | -3.1 | -7,410 | -8 | |
| 2021Q4 | 91.6 | 100.32 | -3.5 | -8,470 | -10 | |
| 2021Q3 | 125 | 100.26 | -4.9 | -11,768 | -13 | |
| 2021Q2 | 113 | 100.31 | -4.2 | -10,730 | -12 |